Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Reply to 'Comment on 'BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses''.

Papadakis ES, Reeves T, Robson NH, Maishman T, Packham G, Cutress RI.

Br J Cancer. 2018 Apr;118(8):1154. doi: 10.1038/s41416-018-0032-y. Epub 2018 Mar 15. No abstract available.

2.

BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.

Papadakis ES, Reeves T, Robson NH, Maishman T, Packham G, Cutress RI.

Br J Cancer. 2017 Jun 6;116(12):1585-1594. doi: 10.1038/bjc.2017.130. Epub 2017 May 16. Review.

3.

Regulation of osteoblast development by Bcl-2-associated athanogene-1 (BAG-1).

Greenhough J, Papadakis ES, Cutress RI, Townsend PA, Oreffo ROC, Tare RS.

Sci Rep. 2016 Sep 16;6:33504. doi: 10.1038/srep33504.

4.

The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

Papadakis ES, Barker CR, Syed H, Reeves T, Schwaiger S, Stuppner H, Troppmair J, Blaydes JP, Cutress RI.

Oncogenesis. 2016 Apr 4;5:e215. doi: 10.1038/oncsis.2016.10.

5.

The receptor tyrosine kinase Axl regulates cell-cell adhesion and stemness in cutaneous squamous cell carcinoma.

Cichoń MA, Szentpetery Z, Caley MP, Papadakis ES, Mackenzie IC, Brennan CH, O'Toole EA.

Oncogene. 2014 Aug 7;33(32):4185-92. doi: 10.1038/onc.2013.388. Epub 2013 Sep 23.

PMID:
24056961
6.

Isolation of a novel thioflavin S-derived compound that inhibits BAG-1-mediated protein interactions and targets BRAF inhibitor-resistant cell lines.

Enthammer M, Papadakis ES, Salomé Gachet M, Deutsch M, Schwaiger S, Koziel K, Ashraf MI, Khalid S, Wolber G, Packham G, Cutress RI, Stuppner H, Troppmair J.

Mol Cancer Ther. 2013 Nov;12(11):2400-14. doi: 10.1158/1535-7163.MCT-13-0142. Epub 2013 Sep 18.

7.

Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members.

Papadakis ES, Cichoń MA, Vyas JJ, Patel N, Ghali L, Cerio R, Storey A, O'Toole EA.

J Invest Dermatol. 2011 Feb;131(2):509-17. doi: 10.1038/jid.2010.326. Epub 2010 Nov 11.

8.

The regulation of Bax by c-Jun N-terminal protein kinase (JNK) is a prerequisite to the mitochondrial-induced apoptotic pathway.

Papadakis ES, Finegan KG, Wang X, Robinson AC, Guo C, Kayahara M, Tournier C.

FEBS Lett. 2006 Feb 20;580(5):1320-6. Epub 2006 Jan 26.

9.

Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway.

Wang X, Merritt AJ, Seyfried J, Guo C, Papadakis ES, Finegan KG, Kayahara M, Dixon J, Boot-Handford RP, Cartwright EJ, Mayer U, Tournier C.

Mol Cell Biol. 2005 Jan;25(1):336-45.

10.

Protein tyrosine kinase inhibitor, genistein, enhances apoptosis and cell cycle arrest in K562 cells treated with gamma-irradiation.

Papazisis KT, Zambouli D, Kimoundri OT, Papadakis ES, Vala V, Geromichalos GD, Voyatzi S, Markala D, Destouni E, Boutis L, Kortsaris AH.

Cancer Lett. 2000 Nov 10;160(1):107-13.

PMID:
11098091

Supplemental Content

Loading ...
Support Center